Testicular Cancer Incidence and Mortality by Year, New York State Excl New York City, 1976-2018

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Cases Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Males 95% CI
1976 179 3.6 3.0-4.1 33 0.6 0.4-0.9
1977 177 3.5 3.0-4.1 29 0.5 0.4-0.8
1978 201 4.1 3.5-4.7 35 0.7 0.5-1.0
1979 227 4.6 4.0-5.2 31 0.7 0.4-1.0
1980 236 4.6 4.0-5.2 30 0.6 0.4-0.8
1981 228 4.3 3.8-5.0 28 0.5 0.3-0.7
1982 228 4.4 3.8-5.0 25 0.5 0.3-0.8
1983 250 4.7 4.1-5.3 24 0.5 0.3-0.8
1984 295 5.6 4.9-6.3 17 0.3 0.2-0.5
1985 265 5.0 4.4-5.6 21 0.4 0.2-0.6
1986 254 4.6 4.1-5.3 25 0.5 0.3-0.7
1987 281 5.1 4.5-5.7 22 0.4 0.2-0.6
1988 270 4.8 4.2-5.4 16 0.3 0.2-0.5
1989 268 4.8 4.2-5.4 22 0.4 0.2-0.6
1990 296 5.3 4.7-5.9 16 0.3 0.2-0.5
1991 275 4.9 4.3-5.5 14 0.2 0.1-0.4
1992 298 5.3 4.7-6.0 20 0.4 0.2-0.6
1993 312 5.6 5.0-6.3 24 0.5 0.3-0.7
1994 305 5.5 4.9-6.2 12 0.2 0.1-0.4
1995 313 5.7 5.1-6.4 16 0.3 0.2-0.5
1996 310 5.7 5.1-6.3 21 0.4 0.2-0.6
1997 333 6.2 5.5-6.9 6 0.1 0.0-0.3
1998 342 6.4 5.7-7.1 18 0.3 0.2-0.5
1999 334 6.2 5.6-7.0 14 0.3 0.1-0.4
2000 306 5.7 5.1-6.4 13 0.2 0.1-0.4
2001 329 6.2 5.5-6.9 13 0.3 0.1-0.4
2002 312 5.9 5.3-6.6 24 0.5 0.3-0.7
2003 353 6.7 6.0-7.4 12 0.2 0.1-0.4
2004 330 6.3 5.6-7.0 11 0.2 0.1-0.4
2005 349 6.7 6.0-7.4 8 0.1 0.1-0.3
2006 326 6.2 5.5-6.9 13 0.2 0.1-0.4
2007 352 6.8 6.1-7.5 8 0.1 0.1-0.3
2008 383 7.4 6.7-8.2 11 0.2 0.1-0.4
2009 339 6.5 5.8-7.2 7 0.1 0.1-0.3
2010 359 6.9 6.2-7.7 15 0.3 0.2-0.5
2011 361 6.9 6.2-7.7 9 0.2 0.1-0.3
2012 377 7.3 6.5-8.0 12 0.2 0.1-0.4
2013 342 6.6 5.9-7.4 8 0.1 0.1-0.3
2014 362 7.0 6.3-7.8 15 0.3 0.2-0.5
2015 352 6.7 6.0-7.5 13 0.2 0.1-0.4
2016 373 7.2 6.5-8.0 10 0.2 0.1-0.3
2017 354 6.9 6.2-7.7 9 0.1 0.1-0.3
2018 384 7.5 6.7-8.3 10 0.2 0.1-0.3

Notes

  • Incidence data are provisional, November 2020.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • The data in this table are not identical to the data in the corresponding 2014-2018 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.